fingolimod hydrochloride has been researched along with Skin Diseases, Viral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, G; Hopkins, RS; Kim, E; Okada, CY; White, KP; Wills, A | 1 |
1 other study(ies) available for fingolimod hydrochloride and Skin Diseases, Viral
| Article | Year |
|---|---|
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.
Topics: Biopsy; Epstein-Barr Virus Infections; Fingolimod Hydrochloride; Herpesvirus 4, Human; Humans; In Situ Hybridization; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; RNA, Viral; Skin; Skin Diseases, Viral; Sphingosine 1 Phosphate Receptor Modulators | 2019 |